This question is becoming urgent as the population ages. In many developed countries , the proportion of very elderly is already growing rapidly. We need to assess and optimize our health care for this group. No such audit has been reported in the oldest old.
Elderly patients are less likely than younger patients to receive some specific treatments.
The elderly are at the highest risk for embolic stroke if not treated for NVAF and have the greatest absolute risk reduction with treatment. However, the safety of anticoagulation therapy in the elderly is less certain. The disparity may be because of a difference in anticoagulation therapy management. 6 Elderly patients with NVAF are less likely to be treated. 651 patients with NVAF at 2 community and 2 tertiary care hospitals were reviewed.